JP7009371B2 - バイオポリマーを脱アセチル化するための方法 - Google Patents

バイオポリマーを脱アセチル化するための方法 Download PDF

Info

Publication number
JP7009371B2
JP7009371B2 JP2018534174A JP2018534174A JP7009371B2 JP 7009371 B2 JP7009371 B2 JP 7009371B2 JP 2018534174 A JP2018534174 A JP 2018534174A JP 2018534174 A JP2018534174 A JP 2018534174A JP 7009371 B2 JP7009371 B2 JP 7009371B2
Authority
JP
Japan
Prior art keywords
hydroxylamine
glycosaminoglycan
biopolymer
acid
deacetylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018534174A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019500472A (ja
Inventor
ヨーアン・オルソン
クレイグ・スティーヴン・ハリス
Original Assignee
ガルデルマ エス．エー．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP15202944.3A external-priority patent/EP3187510A1/fr
Priority claimed from EP16172254.1A external-priority patent/EP3252082A1/fr
Priority claimed from EP16172241.8A external-priority patent/EP3252081A1/fr
Priority claimed from EP16172225.1A external-priority patent/EP3252080A1/fr
Application filed by ガルデルマ エス．エー． filed Critical ガルデルマ エス．エー．
Publication of JP2019500472A publication Critical patent/JP2019500472A/ja
Application granted granted Critical
Publication of JP7009371B2 publication Critical patent/JP7009371B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B61/00—Other general methods
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62—Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/0825—Preparations of compounds not comprising Si-Si or Si-cyano linkages
    • C07F7/083—Syntheses without formation of a Si-C bond
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/246—Intercrosslinking of at least two polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
    • C08J7/12—Chemical modification
    • C08J7/14—Chemical modification with acids, their salts or anhydrides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
    • C08J2405/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Saccharide Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cardiology (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
JP2018534174A 2015-12-29 2016-12-28 バイオポリマーを脱アセチル化するための方法 Active JP7009371B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP15202944.3A EP3187510A1 (fr) 2015-12-29 2015-12-29 Réticulation de glucides
EP15202944.3 2015-12-29
EP16172225.1 2016-05-31
EP16172241.8 2016-05-31
EP16172254.1 2016-05-31
EP16172254.1A EP3252082A1 (fr) 2016-05-31 2016-05-31 Procédé pour la désacétylation de biopolymères
EP16172241.8A EP3252081A1 (fr) 2016-05-31 2016-05-31 Hydrolyse de liaisons esters de glycosaminoglycanes réticulés par des liaisons amides
EP16172225.1A EP3252080A1 (fr) 2016-05-31 2016-05-31 Procédé de préparation de glycosaminoglycanes réticulés acylés
PCT/EP2016/082774 WO2017114861A1 (fr) 2015-12-29 2016-12-28 Procédé de désacétylation de biopolymères

Publications (2)

Publication Number Publication Date
JP2019500472A JP2019500472A (ja) 2019-01-10
JP7009371B2 true JP7009371B2 (ja) 2022-01-25

Family

ID=57680280

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2018534153A Pending JP2019505506A (ja) 2015-12-29 2016-12-28 アミド結合を切断するための方法
JP2018534174A Active JP7009371B2 (ja) 2015-12-29 2016-12-28 バイオポリマーを脱アセチル化するための方法
JP2018534173A Active JP7015784B2 (ja) 2015-12-29 2016-12-28 炭水化物架橋剤
JP2022008632A Active JP7353400B2 (ja) 2015-12-29 2022-01-24 炭水化物架橋剤
JP2023150040A Pending JP2023164569A (ja) 2015-12-29 2023-09-15 炭水化物架橋剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018534153A Pending JP2019505506A (ja) 2015-12-29 2016-12-28 アミド結合を切断するための方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018534173A Active JP7015784B2 (ja) 2015-12-29 2016-12-28 炭水化物架橋剤
JP2022008632A Active JP7353400B2 (ja) 2015-12-29 2022-01-24 炭水化物架橋剤
JP2023150040A Pending JP2023164569A (ja) 2015-12-29 2023-09-15 炭水化物架橋剤

Country Status (18)

Country Link
US (12) US11254792B2 (fr)
EP (7) EP3623390B1 (fr)
JP (5) JP2019505506A (fr)
KR (3) KR20180120142A (fr)
CN (4) CN108884172A (fr)
BR (2) BR112018013504B1 (fr)
CA (2) CA3010021C (fr)
CY (2) CY1123452T1 (fr)
DK (3) DK3397651T3 (fr)
ES (3) ES2812223T3 (fr)
FI (1) FI3623390T3 (fr)
HU (3) HUE063918T2 (fr)
MX (2) MX2018008111A (fr)
PL (2) PL3623390T3 (fr)
PT (2) PT3397648T (fr)
RU (3) RU2018126365A (fr)
SI (3) SI3397648T1 (fr)
WO (5) WO2017114865A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017114865A1 (fr) 2015-12-29 2017-07-06 Galderma S.A. Hydrolyse de liaisons ester dans des glycosaminoglycanes à réticulation amide
PT3623390T (pt) 2016-05-31 2023-10-27 Galderma Sa Reticulador de hidrato de carbono
WO2019002372A1 (fr) * 2017-06-28 2019-01-03 Nestlé Skin Health Sa Procédé de préparation d'un produit hydrogel
KR20200103758A (ko) 2017-12-22 2020-09-02 네슬레 스킨 헬스 소시에떼 아노님 주사가능한 젤 생성물
EP3581168A1 (fr) * 2018-06-15 2019-12-18 Universiteit Utrecht Holding B.V. Compositions à libération prolongée
CN112955187A (zh) * 2018-09-10 2021-06-11 加利福尼亚大学董事会 二硫醇糖粘液溶解剂和其用途
CN109206537B (zh) * 2018-10-10 2021-04-09 华熙生物科技股份有限公司 一种乙酰化透明质酸钠的制备方法及其应用
EP3659632A1 (fr) 2018-11-29 2020-06-03 Nestlé Skin Health SA Dégradation partielle post-réticulation d'hydrogels d'amide réticulés
KR20210121020A (ko) * 2018-12-21 2021-10-07 갈더마 홀딩 소시에떼 아노님 고체 입자를 봉입한 히드로겔 조성물
JP2023504528A (ja) * 2019-12-02 2023-02-03 ガルデルマ ホールディング エスエー 高分子量美容組成物
EP4135772A4 (fr) * 2020-04-17 2024-04-24 Brendan Patrick Purcell Compositions d'acide hyaluronique à libération contrôlée
WO2023148619A1 (fr) 2022-02-01 2023-08-10 Galderma Holding SA Procédés de production d'hydrogels à base acide hyaluronique réticulés
WO2024057154A1 (fr) * 2022-09-12 2024-03-21 Glycocore Pharma S.R.L. Procédé de conjugaison d'acide hyaluronique et conjugués d'acide hyaluronique ainsi obtenus

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002519481A (ja) 1998-07-06 2002-07-02 フィディア・アドバンスト・バイオポリマーズ・ソシエタ・ア・レスポンサビリタ・リミタータ ヒアルロン酸アミドおよびそれらの誘導体、並びにそれらの製造法
WO2002082078A2 (fr) 2001-04-09 2002-10-17 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. Systemes de detection a enzyme liee activee pour detection et quantification d'acides nucleiques, d'antigenes, d'anticorps et d'autres analytes
WO2002081739A2 (fr) 2001-04-09 2002-10-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Analyse non enzymatique a liaison liposomique avec electrodes en reseau etroitement espacees (nel-ela) pour detecter et quantifier des acides nucleiques
JP2004507588A (ja) 2000-08-31 2004-03-11 フィディア　ファルマチェウティチ　ソシエタ　ペル　アチオニ ヒアルロン酸の新規架橋誘導体
JP2004511588A (ja) 2000-10-10 2004-04-15 エルジー・ライフ・サイエンシーズ・リミテッド ヒアルロン酸の架橋結合型アミド誘導体及びその製造方法。
JP2009507103A (ja) 2005-09-02 2009-02-19 コルバー・ライフサイエンス・リミテツド 架橋多糖およびタンパク質マトリックスならびにそれらの製造方法
WO2014072330A1 (fr) 2012-11-06 2014-05-15 Centre National De La Recherche Scientifique (Cnrs) Hydrogel réagissant au glucose comprenant l'acide hyaluronique (ha) sur lequel est greffé pba
WO2015021092A1 (fr) 2013-08-07 2015-02-12 Arrowhead Research Corporation Polyconjugués pour l'administration de déclencheurs d'arni à des cellules tumorales in vivo

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU730695A1 (ru) * 1977-07-05 1980-04-30 Ордена Ленина Институт Элементоорганических Соединений Ан Ссср Способ получени хитозана
DE3684887D1 (de) * 1985-11-29 1992-05-21 Biomatrix Inc Arzneistoffabgabesysteme auf basis von hyaluronan, dessen derivaten und salzen sowie verfahren zu deren herstellung.
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
JPS62265998A (ja) 1986-03-10 1987-11-18 ボ−ド　オブ　リ−ジエンツ　ザ　ユニヴア−シテイ　オブ　テキサス　システム ヘパラン硫酸エンドグリコシダーゼアッセイ
DE4200080A1 (de) * 1992-01-03 1993-09-30 Reinmueller Johannes Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
JP2855307B2 (ja) * 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
DE4439575A1 (de) 1994-11-05 1996-05-09 Permselect Ges Fuer Zellstrukt Neue Vernetzungsprodukte auf Basis Hyaluronsäure
WO1997011958A1 (fr) 1995-09-29 1997-04-03 The Scripps Research Institute Analyse de signature de proteine
FR2764514B1 (fr) 1997-06-13 1999-09-03 Biopharmex Holding Sa Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
KR19990029749A (ko) 1997-09-17 1999-04-26 미우라 아끼라 2가 반응성 수용성 고분자 유도체 및 이들을 함유하는 복합체
JP4385152B2 (ja) * 1997-09-17 2009-12-16 三菱化学株式会社 ２価反応性水溶性高分子誘導体及びそれを含有する複合体
FR2777193B1 (fr) 1998-04-14 2001-06-08 Coletica Particule a groupement hydroxamique chelatante d'ions metalliques et leur utilisation en cosmetique ou en pharmacie
US6630457B1 (en) 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
IT1303735B1 (it) 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S Acidi ialuronici reticolati e loro usi medici.
GB9902412D0 (en) 1999-02-03 1999-03-24 Fermentech Med Ltd Process
GB9902652D0 (en) 1999-02-05 1999-03-31 Fermentech Med Ltd Process
WO2002008278A2 (fr) 2000-07-21 2002-01-31 Diadexus, Inc. Compositions et procedes relatifs aux genes specifiques aux poumons
FR2826657B1 (fr) * 2001-06-29 2003-09-05 Rhodia Chimie Sa Polymeres derives de polysaccharides comprenant une ou plusieurs fonctions oxime ou amine et utilisations desdits polymeres
ES2385030T3 (es) 2001-06-29 2012-07-17 Medgraft Microtech, Inc. Implantes inyectables biodegradables y procedimientos relacionados con su fabricación y uso
US8524884B2 (en) 2001-10-30 2013-09-03 Colorado State University Research Foundation Outer layer material having entanglement of hydrophobic polymer hostblended with a maleated hydrophobic polymer co-host, and hydrophilic polymer guest
KR20040009891A (ko) * 2002-07-26 2004-01-31 주식회사 엘지생명과학 히알루론산의 유도체 겔 및 그 제조방법
PT102888B (pt) 2002-12-23 2005-04-29 Filipe Manuel Rodrigues Aguiar Processo industrial de producao de acido polilactico (pla) obtido por esterificacao e polimerizacao de acido lactico purificado, sendo o referido acido produzido atraves de um processo fermentativo
TWI251596B (en) 2002-12-31 2006-03-21 Ind Tech Res Inst Method for producing a double-crosslinked hyaluronate material
US7115388B2 (en) * 2003-03-14 2006-10-03 National Institute Of Agrobiological Sciences Production of functional polypeptides originating from silk protein and use thereof
US20160106717A1 (en) 2004-09-24 2016-04-21 Gen Pharma Holdings LLC Cai-based systems and methods for the localized treatment of uveitis
DE102005055385A1 (de) 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
WO2007040557A1 (fr) 2005-09-21 2007-04-12 Surmodics, Inc. Revetements et articles a polysaccharides naturels biodegradables
DE102006013594A1 (de) 2006-03-22 2007-09-27 Biopolymer Gmbh & Co. Kg Quervernetzte Gele von Hyaluronsäure und deren Verwendung
ITRM20080636A1 (it) 2008-11-28 2010-05-29 Univ Palermo Procedimento per la produzione di derivati funzionalizzati dell acido ialuronico e relativi idrogeli.
WO2010065784A2 (fr) * 2008-12-03 2010-06-10 Jakk Group, Inc. Procédés, dispositifs et compositions pour un remplissage dermique
US10105197B1 (en) 2009-03-26 2018-10-23 Fernando Colon Method of treatment for periodontal pockets
EP2413894B1 (fr) * 2009-04-02 2017-01-04 Allergan, Inc. Hydrogels en forme de cheveu pour augmentation des tissus mous
CN102070786B (zh) * 2009-11-19 2012-05-30 中国农业科学院农产品加工研究所 一种透明质酸-海藻酸钠复合水凝胶及其制备方法
US8197849B2 (en) * 2010-02-12 2012-06-12 National Health Research Institutes Cross-linked oxidated hyaluronic acid for use as a vitreous substitute
KR101831918B1 (ko) * 2010-06-11 2018-02-27 한국원자력의학원 히알루론산의 탈아세틸화 가수분해효소, 및 이에 의해 탈아세틸화된 히알루론산 및 이의 유도체
KR101834588B1 (ko) 2010-08-23 2018-03-05 덴카 주식회사 가교 히알루론산 조성물 및 자기 가교 히알루론산 입자
WO2012118189A1 (fr) 2011-03-03 2012-09-07 中外製薬株式会社 Dérivé d'acide hyaluronique modifié par l'acide aminocarbonique
CN103945870B (zh) 2011-09-07 2016-10-12 普罗林科斯有限责任公司 生物可降解交联的水凝胶
KR20210071106A (ko) * 2011-12-08 2021-06-15 알러간 인더스트리 에스에이에스 진피 필러 조성물
US8887243B2 (en) 2012-01-30 2014-11-11 Cisco Technology, Inc. Integrated security platform
CZ304512B6 (cs) * 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
CN102952281B (zh) 2012-09-13 2014-03-19 江苏隆源生物科技有限公司 一种壳寡糖和透明质酸交联凝胶的制备方法
US9597826B2 (en) * 2012-10-30 2017-03-21 Bell Helicopter Textron Inc. Method of repairing, splicing, joining, machining, and stabilizing honeycomb core using pourable structural foam and a structure incorporating the same
CN104140541A (zh) * 2013-05-10 2014-11-12 北京化工大学 注射型透明质酸水凝胶的制备方法及其应用
CA2917715A1 (fr) 2013-07-08 2015-01-15 Denka Company Limited Particules a noyau-coquille de gel d'acide hyaluronique reticule, leur procede de production et materiau medical
US9518630B2 (en) * 2013-08-01 2016-12-13 Specialized Bicycle Components, Inc. Bicycle air spring
CN105658633A (zh) 2013-09-03 2016-06-08 新加坡科技研究局 用于生物医药应用的聚合物-类黄酮缀合物和水凝胶
CN103788222B (zh) * 2014-01-08 2016-08-31 中国科学院昆明植物研究所 Fuc3S4S取代的低聚糖胺聚糖及其制备方法
CA2950050A1 (fr) 2014-05-29 2015-12-03 Galderma S.A. Acide hyaluronique reticule greffe a du dextrane
EP3148600B1 (fr) 2014-05-29 2019-08-07 Galderma S.A. Acide hyaluronique à greffe de cyclodextrine réticulé avec un dextrane et ses utilisations
CN104194066B (zh) * 2014-09-15 2016-08-24 中国科学院上海硅酸盐研究所 氧化硅-壳聚糖复合气凝胶及其制备方法
CN105288594A (zh) * 2015-11-30 2016-02-03 武汉理工大学 一种被可注射水凝胶包裹的生长因子多孔微球复合系统
WO2017114865A1 (fr) * 2015-12-29 2017-07-06 Galderma S.A. Hydrolyse de liaisons ester dans des glycosaminoglycanes à réticulation amide
WO2019001784A1 (fr) 2017-06-28 2019-01-03 Nestlé Skin Health Sa Gel d'acide hyaluronique avec un cation divalent
WO2019002370A1 (fr) 2017-06-28 2019-01-03 Nestlé Skin Health Sa Glycosaminoglycanes réticulés et fonctionnalisés
WO2019002368A1 (fr) 2017-06-28 2019-01-03 Nestlé Skin Health Sa Glycosaminoglycanes réticulés et fonctionnalisés
US10889894B2 (en) * 2018-08-06 2021-01-12 Applied Materials, Inc. Faceplate with embedded heater

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002519481A (ja) 1998-07-06 2002-07-02 フィディア・アドバンスト・バイオポリマーズ・ソシエタ・ア・レスポンサビリタ・リミタータ ヒアルロン酸アミドおよびそれらの誘導体、並びにそれらの製造法
JP2004507588A (ja) 2000-08-31 2004-03-11 フィディア　ファルマチェウティチ　ソシエタ　ペル　アチオニ ヒアルロン酸の新規架橋誘導体
JP2004511588A (ja) 2000-10-10 2004-04-15 エルジー・ライフ・サイエンシーズ・リミテッド ヒアルロン酸の架橋結合型アミド誘導体及びその製造方法。
WO2002082078A2 (fr) 2001-04-09 2002-10-17 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. Systemes de detection a enzyme liee activee pour detection et quantification d'acides nucleiques, d'antigenes, d'anticorps et d'autres analytes
WO2002081739A2 (fr) 2001-04-09 2002-10-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Analyse non enzymatique a liaison liposomique avec electrodes en reseau etroitement espacees (nel-ela) pour detecter et quantifier des acides nucleiques
JP2009507103A (ja) 2005-09-02 2009-02-19 コルバー・ライフサイエンス・リミテツド 架橋多糖およびタンパク質マトリックスならびにそれらの製造方法
WO2014072330A1 (fr) 2012-11-06 2014-05-15 Centre National De La Recherche Scientifique (Cnrs) Hydrogel réagissant au glucose comprenant l'acide hyaluronique (ha) sur lequel est greffé pba
WO2015021092A1 (fr) 2013-08-07 2015-02-12 Arrowhead Research Corporation Polyconjugués pour l'administration de déclencheurs d'arni à des cellules tumorales in vivo

Also Published As

Publication number Publication date
JP2022048242A (ja) 2022-03-25
HUE050124T2 (hu) 2020-11-30
US20190023855A1 (en) 2019-01-24
KR20180121493A (ko) 2018-11-07
US20190010113A1 (en) 2019-01-10
US20190023812A1 (en) 2019-01-24
CA3010161C (fr) 2024-01-16
WO2017114865A1 (fr) 2017-07-06
RU2748235C2 (ru) 2021-05-21
EP3397648B1 (fr) 2020-05-27
JP2019505506A (ja) 2019-02-28
US20230416469A1 (en) 2023-12-28
ES2812223T3 (es) 2021-03-16
HUE050221T2 (hu) 2020-11-30
EP3397648A1 (fr) 2018-11-07
EP3623390B1 (fr) 2023-08-02
CN116284867A (zh) 2023-06-23
PL3397651T3 (pl) 2021-02-08
RU2018126376A3 (fr) 2020-08-27
MX2018008111A (es) 2018-11-29
RU2733145C2 (ru) 2020-09-29
WO2017114867A1 (fr) 2017-07-06
KR20180121492A (ko) 2018-11-07
US11939433B2 (en) 2024-03-26
CA3010021C (fr) 2024-01-02
US10899894B2 (en) 2021-01-26
EP3397650A1 (fr) 2018-11-07
US20220169804A1 (en) 2022-06-02
US20220177655A1 (en) 2022-06-09
CN108779184B (zh) 2023-04-21
US20230323041A1 (en) 2023-10-12
RU2018126365A (ru) 2020-01-30
BR112018013523A2 (pt) 2018-12-04
ES2962687T3 (es) 2024-03-20
PL3623390T3 (pl) 2024-04-02
US11780970B2 (en) 2023-10-10
JP2023164569A (ja) 2023-11-10
US11708461B2 (en) 2023-07-25
JP2019500472A (ja) 2019-01-10
CN108779184A (zh) 2018-11-09
HUE063918T2 (hu) 2024-02-28
SI3623390T1 (sl) 2023-12-29
EP3397652A1 (fr) 2018-11-07
PT3397648T (pt) 2020-08-26
RU2018126376A (ru) 2020-01-30
US20210108036A1 (en) 2021-04-15
SI3397648T1 (sl) 2020-12-31
US11530301B2 (en) 2022-12-20
KR20180120142A (ko) 2018-11-05
EP3397649B1 (fr) 2020-05-27
WO2017114864A1 (fr) 2017-07-06
FI3623390T3 (fi) 2023-10-30
US11643509B2 (en) 2023-05-09
SI3397651T1 (sl) 2020-11-30
EP4279537A2 (fr) 2023-11-22
US11066526B2 (en) 2021-07-20
DK3397651T3 (da) 2020-08-10
CA3010021A1 (fr) 2017-07-06
EP3397649A1 (fr) 2018-11-07
CY1123455T1 (el) 2022-03-24
DK3623390T3 (da) 2023-09-25
ES2810013T3 (es) 2021-03-08
US20230102832A1 (en) 2023-03-30
US11198765B2 (en) 2021-12-14
EP3397651B1 (fr) 2020-05-06
DK3397648T3 (da) 2020-08-31
JP2019500388A (ja) 2019-01-10
JP7015784B2 (ja) 2022-02-15
BR112018013523B1 (pt) 2022-06-14
CY1123452T1 (el) 2022-03-24
CA3010161A1 (fr) 2017-07-06
WO2017114859A1 (fr) 2017-07-06
JP7353400B2 (ja) 2023-09-29
BR112018013504A2 (pt) 2018-12-04
EP3623390A1 (fr) 2020-03-18
EP3397651A1 (fr) 2018-11-07
US20200030219A1 (en) 2020-01-30
US11254792B2 (en) 2022-02-22
BR112018013504B1 (pt) 2022-08-09
PT3397651T (pt) 2020-08-05
US20190016830A1 (en) 2019-01-17
CN108884172A (zh) 2018-11-23
EP4279537A3 (fr) 2024-02-21
MX2018008110A (es) 2018-11-12
US20230212360A1 (en) 2023-07-06
RU2018126372A3 (fr) 2020-04-29
RU2018126372A (ru) 2020-01-31
CN108884173A (zh) 2018-11-23
WO2017114861A1 (fr) 2017-07-06

Similar Documents

Publication Publication Date Title
JP7009371B2 (ja) バイオポリマーを脱アセチル化するための方法
EP3187510A1 (fr) Réticulation de glucides
EP3252081A1 (fr) Hydrolyse de liaisons esters de glycosaminoglycanes réticulés par des liaisons amides
EP3252082A1 (fr) Procédé pour la désacétylation de biopolymères
EP3252080A1 (fr) Procédé de préparation de glycosaminoglycanes réticulés acylés

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180829

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191108

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201005

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201217

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210517

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210915

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20210915

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20211109

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20211115

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20211213

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220112

R150 Certificate of patent or registration of utility model

Ref document number: 7009371

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150